[HTML][HTML] Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

U Anand, A Dey, AKS Chandel, R Sanyal, A Mishra… - Genes & …, 2023 - Elsevier
Cancer is an abnormal state of cells where they undergo uncontrolled proliferation and
produce aggressive malignancies that causes millions of deaths every year. With the new …

From purines to purinergic signalling: molecular functions and human diseases

Z Huang, N Xie, P Illes, F Di Virgilio, H Ulrich… - Signal transduction and …, 2021 - nature.com
Purines and their derivatives, most notably adenosine and ATP, are the key molecules
controlling intracellular energy homoeostasis and nucleotide synthesis. Besides, these …

[HTML][HTML] Mechanisms of macrophage plasticity in the tumor environment: manipulating activation state to improve outcomes

TD Ricketts, N Prieto-Dominguez, PS Gowda… - Frontiers in …, 2021 - frontiersin.org
Macrophages are a specialized class of innate immune cells with multifaceted roles in
modulation of the inflammatory response, homeostasis, and wound healing. While …

P2X7 in cancer: from molecular mechanisms to therapeutics

R Lara, E Adinolfi, CA Harwood, M Philpott… - Frontiers in …, 2020 - frontiersin.org
P2X7 is a transmembrane receptor expressed in multiple cell types including neurons,
dendritic cells, macrophages, monocytes, B and T cells where it can drive a wide range of …

Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapy

Y Zeng, C Zhang, D Du, Y Li, L Sun, Y Han, X He, J Dai… - Acta Biomaterialia, 2022 - Elsevier
Metal-organic framework (MOF) is an exciting class of porous biomaterials that have been
considered as a carrier to store and deliver therapeutic drugs. However, similar to other …

DNA logic circuits for cancer theranostics

J Chen, S Fu, C Zhang, H Liu, X Su - Small, 2022 - Wiley Online Library
Cancer diagnosis and therapeutics (theranostics) based on the tumor microenvironment
(TME) and biomarkers has been an emerging approach for precision medicine. DNA …

The role of purinergic P2X7 receptor in inflammation and cancer: novel molecular insights and clinical applications

JC Rotondo, C Mazziotta, C Lanzillotti, C Stefani… - Cancers, 2022 - mdpi.com
Simple Summary The purinergic P2X7 receptor (P2X7R) is a cell membrane protein whose
activation has been related to a variety of cellular processes, while its dysregulation has …

Antibodies and venom peptides: new modalities for ion channels

H Wulff, P Christophersen, P Colussi… - Nature Reviews Drug …, 2019 - nature.com
Ion channels play fundamental roles in both excitable and non-excitable tissues and
therefore constitute attractive drug targets for myriad neurological, cardiovascular and …

Purinergic signaling in the hallmarks of cancer

AR Campos-Contreras, M Díaz-Muñoz… - Cells, 2020 - mdpi.com
Cancer is a complex expression of an altered state of cellular differentiation associated with
severe clinical repercussions. The effort to characterize this pathological entity to understand …

[HTML][HTML] Potassium channels as a target for cancer therapy: Current perspectives

L Zúñiga, A Cayo, W González, C Vilos… - OncoTargets and …, 2022 - ncbi.nlm.nih.gov
Potassium (K+) channels are highly regulated membrane proteins that control the potassium
ion flux and respond to different cellular stimuli. These ion channels are grouped into three …